speb/financial-data huggingface dataset:
ANGI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1606000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 166929000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 1606000.00
ANGI income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 32770000.00
ANGI income_statement (quarterly, 2025-06-30) — Normalized Income: 10897000.00
ANGI cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 57121000.00
ANGI income_statement (quarterly, 2025-06-30) — Operating Income: 17673000.00
ANGI income_statement (quarterly, 2025-06-30) — Operating Revenue: 278221000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 45131000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 35941000.00
ANGI income_statement (quarterly, 2025-06-30) — Other Gand A: 74081000.00
ANGI income_statement (quarterly, 2025-06-30) — Other Income Expense: 941000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 168931000.00
ANGI cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1124000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 32392000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 39810000.00
ANGI income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 941000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Payables: 39804000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 214950000.00
ANGI income_statement (quarterly, 2025-06-30) — Pretax Income: 17441000.00
ANGI cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 12729000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Receivables: 44811000.00
ANGI income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 13142000.00
ANGI income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 10278000.00
ANGI cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -66585000.00
ANGI income_statement (quarterly, 2025-06-30) — Research And Development: 23594000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -169012000.00
ANGI cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
ANGI income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 139453000.00
ANGI income_statement (quarterly, 2025-06-30) — Selling General And Administration: 213534000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Share Issued: 54074000.00
ANGI cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 5054000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1002224000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -56638000.00
ANGI income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ANGI income_statement (quarterly, 2025-06-30) — Tax Provision: 6544000.00
ANGI income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.38
ANGI balance_sheet (quarterly, 2025-06-30) — Total Assets: 1788790000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1499472000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Total Debt: 497248000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1002224000.00
ANGI income_statement (quarterly, 2025-06-30) — Total Expenses: 260548000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 786566000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1345561000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 538664000.00
ANGI income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 17673000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 8943000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 284565000.00
ANGI balance_sheet (quarterly, 2025-06-30) — Working Capital: 195327000.00
ANGI income_statement (quarterly, 2025-09-30) — +Operating Expense: 231391000.00
ANGI income_statement (quarterly, 2025-09-30) — +Total Revenue: 265633000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 38897000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 38354000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -237471000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1455785000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -18992000.00
ANGI income_statement (quarterly, 2025-09-30) — Basic Average Shares: 44294000.00
ANGI income_statement (quarterly, 2025-09-30) — Basic EPS: 0.24
ANGI cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 362477000.00
ANGI cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -16048000.00
ANGI cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -16048000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Capital Stock: 537000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 340689000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 340689000.00
ANGI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -26407000.00
ANGI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -16048000.00
ANGI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 20981000.00
ANGI cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -26223000.00
ANGI cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 7797000.00
ANGI cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -3295000.00
ANGI cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -3560000.00
ANGI cash_flow (quarterly, 2025-09-30) — Change In Payable: -26223000.00
ANGI cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -26223000.00
ANGI cash_flow (quarterly, 2025-09-30) — Change In Receivables: -6724000.00
ANGI cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -32005000.00
ANGI cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -6724000.00
ANGI cash_flow (quarterly, 2025-09-30) — Changes In Cash: -21474000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Common Stock: 537000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 994070000.00
ANGI cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -26271000.00
ANGI income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 12460000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 146401000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Current Assets: 407363000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 29937000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 29937000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 215235000.00
ANGI cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 9470000.00
ANGI cash_flow (quarterly, 2025-09-30) — Deferred Tax: 9470000.00
ANGI cash_flow (quarterly, 2025-09-30) — Depreciation: 11918000.00
ANGI cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 11918000.00
ANGI income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 11918000.00
ANGI cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 11918000.00
ANGI income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 11918000.00
ANGI income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 11918000.00
ANGI income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 45133000.00
ANGI income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.23
ANGI income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 10605000.00
ANGI income_statement (quarterly, 2025-09-30) — EBIT: 25872000.00
ANGI income_statement (quarterly, 2025-09-30) — EBITDA: 37790000.00
ANGI cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -314000.00
ANGI cash_flow (quarterly, 2025-09-30) — End Cash Position: 340689000.00
ANGI cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -26407000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Foreign Currency Translation Adjustments: 5816000.00
ANGI cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 4933000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 5816000.00
ANGI income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 69410000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Goodwill: 889662000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1058517000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 57346000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Gross PPE: 330565000.00
ANGI income_statement (quarterly, 2025-09-30) — Gross Profit: 253173000.00
ANGI income_statement (quarterly, 2025-09-30) — Interest Expense: 5069000.00
ANGI income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 5069000.00
ANGI income_statement (quarterly, 2025-09-30) — Interest Income: 3833000.00
ANGI income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 3833000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1491527000.00
ANGI cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -16048000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 497457000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 497457000.00
ANGI income_statement (quarterly, 2025-09-30) — Minority Interests: 0.00
ANGI cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -26271000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Net Debt: 156768000.00
ANGI income_statement (quarterly, 2025-09-30) — Net Income: 10605000.00
ANGI income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 10605000.00
ANGI income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 10605000.00
ANGI income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 10605000.00
ANGI income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 10605000.00
ANGI cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 10605000.00
ANGI income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 10605000.00
ANGI income_statement (quarterly, 2025-09-30) — Net Interest Income: -1236000.00
ANGI income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1236000.00
ANGI cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -136000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Net PPE: 93094000.00
ANGI cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
ANGI balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -64447000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 157276000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1023000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 157276000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1023000.00
ANGI income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 37790000.00
ANGI income_statement (quarterly, 2025-09-30) — Normalized Income: 10605000.00
ANGI cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 20981000.00
ANGI income_statement (quarterly, 2025-09-30) — Operating Income: 21782000.00
ANGI income_statement (quarterly, 2025-09-30) — Operating Revenue: 265633000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 43687000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 28320000.00
ANGI income_statement (quarterly, 2025-09-30) — Other Gand A: 69410000.00
ANGI income_statement (quarterly, 2025-09-30) — Other Income Expense: 257000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 168855000.00
ANGI cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1781000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 31141000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 39606000.00
ANGI income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 257000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Payables: 38897000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 185298000.00
ANGI income_statement (quarterly, 2025-09-30) — Pretax Income: 20803000.00
ANGI cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 13230000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Receivables: 38354000.00
ANGI income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 12460000.00
ANGI income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 11918000.00
ANGI cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -26271000.00
ANGI income_statement (quarterly, 2025-09-30) — Research And Development: 20749000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -158104000.00
ANGI cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
ANGI income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 129314000.00
ANGI income_statement (quarterly, 2025-09-30) — Selling General And Administration: 198724000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Share Issued: 54140000.00
ANGI cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 5982000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 994070000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -64447000.00
ANGI income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ANGI income_statement (quarterly, 2025-09-30) — Tax Provision: 10198000.00
ANGI income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
ANGI balance_sheet (quarterly, 2025-09-30) — Total Assets: 1747391000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1491527000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Total Debt: 497457000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 994070000.00
ANGI income_statement (quarterly, 2025-09-30) — Total Expenses: 243851000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 753321000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1340028000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 538086000.00
ANGI income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 21782000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 10453000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 309964000.00
ANGI balance_sheet (quarterly, 2025-09-30) — Working Capital: 192128000.00
ANGI income_statement (annual, 2025-12-31) — +Operating Expense: 904904000.00
ANGI income_statement (quarterly, 2025-12-31) — +Operating Expense: 213212000.00
ANGI income_statement (annual, 2025-12-31) — +Total Revenue: 1030535000.00
ANGI income_statement (quarterly, 2025-12-31) — +Total Revenue: 240768000.00
ANGI balance_sheet (annual, 2025-12-31) — Accounts Payable: 34031000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 34031000.00
ANGI balance_sheet (annual, 2025-12-31) — Accounts Receivable: 33054000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 33054000.00
ANGI balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -222024000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -222024000.00
ANGI balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1427693000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1427693000.00
ANGI balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -15890000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -15890000.00
ANGI income_statement (annual, 2025-12-31) — Amortization: 1800000.00
ANGI cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 1800000.00
ANGI cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 1800000.00
ANGI income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 1800000.00
ANGI income_statement (annual, 2025-12-31) — Basic Average Shares: 45658333.00
ANGI income_statement (quarterly, 2025-12-31) — Basic Average Shares: 42494118.00
ANGI income_statement (annual, 2025-12-31) — Basic EPS: 0.96
ANGI income_statement (quarterly, 2025-12-31) — Basic EPS: 0.17
ANGI cash_flow (annual, 2025-12-31) — Beginning Cash Position: 416545000.00
ANGI cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 340689000.00
ANGI cash_flow (annual, 2025-12-31) — Capital Expenditure: -59600000.00
ANGI cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -18728000.00
ANGI cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -59600000.00
ANGI cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -18728000.00
ANGI balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 13460000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 13460000.00
ANGI balance_sheet (annual, 2025-12-31) — Capital Stock: 538000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Capital Stock: 538000.00
ANGI balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 303701000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 303701000.00
ANGI balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 303701000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 303701000.00
ANGI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -158342000.00
ANGI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -48778000.00
ANGI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -59455000.00
ANGI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -18658000.00
ANGI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 105073000.00
ANGI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 30084000.00
ANGI cash_flow (annual, 2025-12-31) — Change In Account Payable: -3825000.00
ANGI cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 10040000.00
ANGI cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 13391000.00
ANGI cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -1081000.00
ANGI cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -13070000.00
ANGI cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -3325000.00
ANGI cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -21211000.00
ANGI cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -7293000.00
ANGI cash_flow (annual, 2025-12-31) — Change In Payable: -3825000.00
ANGI cash_flow (quarterly, 2025-12-31) — Change In Payable: 10040000.00
ANGI cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -3825000.00
ANGI cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 10040000.00
ANGI cash_flow (annual, 2025-12-31) — Change In Receivables: -43754000.00
ANGI cash_flow (quarterly, 2025-12-31) — Change In Receivables: -5891000.00
ANGI cash_flow (annual, 2025-12-31) — Change In Working Capital: -68469000.00
ANGI cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -7550000.00
ANGI cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -43754000.00
ANGI cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -5891000.00
ANGI cash_flow (annual, 2025-12-31) — Changes In Cash: -112724000.00
ANGI cash_flow (quarterly, 2025-12-31) — Changes In Cash: -37352000.00
ANGI balance_sheet (annual, 2025-12-31) — Common Stock: 538000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Common Stock: 538000.00
ANGI balance_sheet (annual, 2025-12-31) — Common Stock Equity: 927366000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 927366000.00
ANGI cash_flow (annual, 2025-12-31) — Common Stock Payments: -148676000.00
ANGI cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -46019000.00
ANGI balance_sheet (annual, 2025-12-31) — Construction In Progress: 22742000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 22742000.00
ANGI income_statement (annual, 2025-12-31) — Cost Of Revenue: 47436000.00
ANGI income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 8819000.00
ANGI balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 28337000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 28337000.00
ANGI balance_sheet (annual, 2025-12-31) — Current Assets: 366382000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Current Assets: 366382000.00
ANGI balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 13460000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 13460000.00
ANGI balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 13460000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 13460000.00
ANGI balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 7866000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 7866000.00
ANGI balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 22096000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 22096000.00
ANGI balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 22096000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 22096000.00
ANGI balance_sheet (annual, 2025-12-31) — Current Liabilities: 222438000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 222438000.00
ANGI cash_flow (annual, 2025-12-31) — Deferred Income Tax: 13166000.00
ANGI cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -3728000.00
ANGI cash_flow (annual, 2025-12-31) — Deferred Tax: 13166000.00
ANGI cash_flow (quarterly, 2025-12-31) — Deferred Tax: -3728000.00
ANGI cash_flow (annual, 2025-12-31) — Depreciation: 45319000.00
ANGI cash_flow (quarterly, 2025-12-31) — Depreciation: 13175000.00
ANGI cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 47119000.00
ANGI cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 14975000.00
ANGI income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 47119000.00
ANGI income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 14975000.00
ANGI cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 47119000.00
ANGI cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 14975000.00
ANGI income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 47119000.00
ANGI income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 14975000.00
ANGI income_statement (annual, 2025-12-31) — Depreciation Income Statement: 45319000.00
ANGI income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 13175000.00
ANGI income_statement (annual, 2025-12-31) — Diluted Average Shares: 46629787.00
ANGI income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 42494118.00
ANGI income_statement (annual, 2025-12-31) — Diluted EPS: 0.94
ANGI income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.17
ANGI income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 43832000.00
ANGI income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 7224000.00
ANGI income_statement (annual, 2025-12-31) — EBIT: 82996000.00
ANGI income_statement (quarterly, 2025-12-31) — EBIT: 9801000.00
ANGI income_statement (annual, 2025-12-31) — EBITDA: 130115000.00
ANGI income_statement (quarterly, 2025-12-31) — EBITDA: 24776000.00
ANGI cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -120000.00
ANGI cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 364000.00
ANGI cash_flow (annual, 2025-12-31) — End Cash Position: 303701000.00
ANGI cash_flow (quarterly, 2025-12-31) — End Cash Position: 303701000.00
ANGI cash_flow (annual, 2025-12-31) — Financing Cash Flow: -158342000.00
ANGI cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -48778000.00
ANGI balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: 5938000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: 5938000.00
ANGI cash_flow (annual, 2025-12-31) — Free Cash Flow: 45473000.00
ANGI cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 11356000.00
ANGI balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 5938000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 5938000.00
ANGI income_statement (annual, 2025-12-31) — General And Administrative Expense: 262878000.00
ANGI income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 62068000.00
ANGI balance_sheet (annual, 2025-12-31) — Goodwill: 890066000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Goodwill: 890066000.00
ANGI balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 1057208000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 1057208000.00
ANGI balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 48944000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 48944000.00
ANGI balance_sheet (annual, 2025-12-31) — Gross PPE: 321125000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Gross PPE: 321125000.00
ANGI income_statement (annual, 2025-12-31) — Gross Profit: 983099000.00
ANGI income_statement (quarterly, 2025-12-31) — Gross Profit: 231949000.00
ANGI cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 7551000.00
ANGI income_statement (annual, 2025-12-31) — Interest Expense: 20469000.00
ANGI income_statement (quarterly, 2025-12-31) — Interest Expense: 5305000.00
ANGI income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 20469000.00
ANGI income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 5305000.00
ANGI income_statement (annual, 2025-12-31) — Interest Income: 15745000.00
ANGI income_statement (quarterly, 2025-12-31) — Interest Income: 3718000.00
ANGI income_statement (annual, 2025-12-31) — Interest Income Non Operating: 15745000.00
ANGI income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 3718000.00
ANGI cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 19375000.00
ANGI balance_sheet (annual, 2025-12-31) — Invested Capital: 1425033000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1425033000.00
ANGI cash_flow (annual, 2025-12-31) — Investing Cash Flow: -59455000.00
ANGI cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -18658000.00
ANGI balance_sheet (annual, 2025-12-31) — Leases: 13454000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Leases: 13454000.00
ANGI balance_sheet (annual, 2025-12-31) — Long Term Debt: 497667000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 497667000.00
ANGI balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 497667000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 497667000.00
ANGI balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 284929000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 284929000.00
ANGI income_statement (annual, 2025-12-31) — Minority Interests: 0.00
ANGI income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
ANGI cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
ANGI cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -148676000.00
ANGI cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -46019000.00
ANGI balance_sheet (annual, 2025-12-31) — Net Debt: 193966000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Net Debt: 193966000.00
ANGI income_statement (annual, 2025-12-31) — Net Income: 43832000.00
ANGI income_statement (quarterly, 2025-12-31) — Net Income: 7224000.00
ANGI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 43832000.00
ANGI income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 7224000.00
ANGI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 43832000.00
ANGI income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 7224000.00
ANGI income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
ANGI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 43832000.00
ANGI income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 7224000.00
ANGI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 43832000.00
ANGI income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 7224000.00
ANGI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 43832000.00
ANGI cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 7224000.00
ANGI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 43832000.00
ANGI income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 7224000.00
ANGI income_statement (annual, 2025-12-31) — Net Interest Income: -4724000.00
ANGI income_statement (quarterly, 2025-12-31) — Net Interest Income: -1587000.00
ANGI cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
ANGI income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -4724000.00
ANGI income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1587000.00
ANGI cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -9666000.00
ANGI cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -2759000.00
ANGI balance_sheet (annual, 2025-12-31) — Net PPE: 99101000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Net PPE: 99101000.00
ANGI cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 145000.00
ANGI cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 70000.00
ANGI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -129842000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -129842000.00
ANGI balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 126229000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 126229000.00
ANGI balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 1498000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1498000.00
ANGI balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 126229000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 126229000.00
ANGI balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1498000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1498000.00
ANGI income_statement (annual, 2025-12-31) — Normalized EBITDA: 142904000.00
ANGI income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 24776000.00
ANGI income_statement (annual, 2025-12-31) — Normalized Income: 52797206.20
ANGI income_statement (quarterly, 2025-12-31) — Normalized Income: 7224000.00
ANGI cash_flow (annual, 2025-12-31) — Operating Cash Flow: 105073000.00
ANGI cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 30084000.00
ANGI income_statement (annual, 2025-12-31) — Operating Income: 78195000.00
ANGI income_statement (quarterly, 2025-12-31) — Operating Income: 18737000.00
ANGI income_statement (annual, 2025-12-31) — Operating Revenue: 1030535000.00
ANGI income_statement (quarterly, 2025-12-31) — Operating Revenue: 240768000.00
ANGI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 40062000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 40062000.00
ANGI cash_flow (annual, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: 0.00
ANGI balance_sheet (annual, 2025-12-31) — Other Current Assets: 6226000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 6226000.00
ANGI balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 83292000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 83292000.00
ANGI income_statement (annual, 2025-12-31) — Other Gand A: 262878000.00
ANGI income_statement (quarterly, 2025-12-31) — Other Gand A: 62068000.00
ANGI income_statement (annual, 2025-12-31) — Other Income Expense: -10944000.00
ANGI income_statement (quarterly, 2025-12-31) — Other Income Expense: -12654000.00
ANGI balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 167142000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 167142000.00
ANGI cash_flow (annual, 2025-12-31) — Other Non Cash Items: 6176000.00
ANGI cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1936000.00
ANGI balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 31448000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 31448000.00
ANGI balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 31399000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 31399000.00
ANGI income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 1845000.00
ANGI income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 135000.00
ANGI balance_sheet (annual, 2025-12-31) — Payables: 34031000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Payables: 34031000.00
ANGI balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 62368000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 62368000.00
ANGI balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 41222000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 41222000.00
ANGI balance_sheet (annual, 2025-12-31) — Prepaid Assets: 15535000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 15535000.00
ANGI income_statement (annual, 2025-12-31) — Pretax Income: 62527000.00
ANGI income_statement (quarterly, 2025-12-31) — Pretax Income: 4496000.00
ANGI balance_sheet (annual, 2025-12-31) — Properties: 0.00
ANGI balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ANGI cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 48491000.00
ANGI cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 11218000.00
ANGI cash_flow (annual, 2025-12-31) — Purchase Of Investment: 0.00
ANGI balance_sheet (annual, 2025-12-31) — Receivables: 33054000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Receivables: 33054000.00
ANGI income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 47436000.00
ANGI income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 8819000.00
ANGI income_statement (annual, 2025-12-31) — Reconciled Depreciation: 47119000.00
ANGI income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 14975000.00
ANGI cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -148676000.00
ANGI cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -46019000.00
ANGI income_statement (annual, 2025-12-31) — Research And Development: 87361000.00
ANGI income_statement (quarterly, 2025-12-31) — Research And Development: 15931000.00
ANGI income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 12789000.00
ANGI balance_sheet (annual, 2025-12-31) — Retained Earnings: -150880000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -150880000.00
ANGI cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
ANGI cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
ANGI cash_flow (annual, 2025-12-31) — Sale Of PPE: 145000.00
ANGI cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 70000.00
ANGI income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 507546000.00
ANGI income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 120238000.00
ANGI income_statement (annual, 2025-12-31) — Selling General And Administration: 770424000.00
ANGI income_statement (quarterly, 2025-12-31) — Selling General And Administration: 182306000.00
ANGI balance_sheet (annual, 2025-12-31) — Share Issued: 54282000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Share Issued: 54282000.00
ANGI income_statement (annual, 2025-12-31) — Special Income Charges: -12789000.00
ANGI cash_flow (annual, 2025-12-31) — Stock Based Compensation: 14758000.00
ANGI cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 6009000.00
ANGI balance_sheet (annual, 2025-12-31) — Stockholders Equity: 927366000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 927366000.00
ANGI balance_sheet (annual, 2025-12-31) — Tangible Book Value: -129842000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -129842000.00
ANGI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -3823793.80
ANGI income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ANGI income_statement (annual, 2025-12-31) — Tax Provision: 18695000.00
ANGI income_statement (quarterly, 2025-12-31) — Tax Provision: -2728000.00
ANGI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.30
ANGI income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
ANGI balance_sheet (annual, 2025-12-31) — Total Assets: 1680368000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Total Assets: 1680368000.00
ANGI balance_sheet (annual, 2025-12-31) — Total Capitalization: 1425033000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1425033000.00
ANGI balance_sheet (annual, 2025-12-31) — Total Debt: 511127000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Total Debt: 511127000.00
ANGI balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 927366000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 927366000.00
ANGI income_statement (annual, 2025-12-31) — Total Expenses: 952340000.00
ANGI income_statement (quarterly, 2025-12-31) — Total Expenses: 222031000.00
ANGI balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 753002000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 753002000.00
ANGI balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1313986000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1313986000.00
ANGI balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 530564000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 530564000.00
ANGI income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 65406000.00
ANGI income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 5948000.00
ANGI income_statement (annual, 2025-12-31) — Total Unusual Items: -12789000.00
ANGI income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -12789000.00
ANGI balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 14220000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 14220000.00
ANGI balance_sheet (annual, 2025-12-31) — Treasury Stock: 355923000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 355923000.00
ANGI balance_sheet (annual, 2025-12-31) — Working Capital: 143944000.00
ANGI balance_sheet (quarterly, 2025-12-31) — Working Capital: 143944000.00
ANGI income_statement (quarterly, 2026-03-31) — +Operating Expense: 222998000.00
ANGI income_statement (quarterly, 2026-03-31) — +Total Revenue: 238150000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 35065000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 37366000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1424207000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -18795000.00
ANGI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 40152000.00
ANGI income_statement (quarterly, 2026-03-31) — Basic EPS: -0.22
ANGI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 303701000.00
ANGI cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -15725000.00
ANGI cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -15725000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 538000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 244580000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 244580000.00
ANGI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -25542000.00
ANGI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -15693000.00
ANGI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -17903000.00
ANGI cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -16285000.00
ANGI cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 851000.00
ANGI cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -3461000.00
ANGI cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -3132000.00
ANGI cash_flow (quarterly, 2026-03-31) — Change In Payable: -16285000.00
ANGI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -16285000.00
ANGI cash_flow (quarterly, 2026-03-31) — Change In Receivables: -14790000.00
ANGI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -36817000.00
ANGI cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -14790000.00
ANGI cash_flow (quarterly, 2026-03-31) — Changes In Cash: -59138000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Common Stock: 538000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 914724000.00
ANGI cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
ANGI income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 9693000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 153137000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Current Assets: 313304000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 20996000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 20996000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 209198000.00
ANGI cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 482000.00
ANGI cash_flow (quarterly, 2026-03-31) — Deferred Tax: 482000.00
ANGI cash_flow (quarterly, 2026-03-31) — Depreciation: 14694000.00
ANGI cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 14694000.00
ANGI income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 14694000.00
ANGI cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 14694000.00
ANGI income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 14694000.00
ANGI income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 14694000.00
ANGI income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 40152000.00
ANGI income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.22
ANGI income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -8978000.00
ANGI income_statement (quarterly, 2026-03-31) — EBIT: -4365000.00
ANGI income_statement (quarterly, 2026-03-31) — EBITDA: 10329000.00
ANGI cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 17000.00
ANGI cash_flow (quarterly, 2026-03-31) — End Cash Position: 244580000.00
ANGI cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -25542000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: 5760000.00
ANGI cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -33628000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 5760000.00
ANGI income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 57931000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Goodwill: 889220000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1056198000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 56161000.00
ANGI income_statement (quarterly, 2026-03-31) — Gross Profit: 228457000.00
ANGI income_statement (quarterly, 2026-03-31) — Interest Expense: 5330000.00
ANGI income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 5330000.00
ANGI income_statement (quarterly, 2026-03-31) — Interest Income: 2508000.00
ANGI income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 2508000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1386113000.00
ANGI cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -15693000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 471389000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 471389000.00
ANGI cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -23744000.00
ANGI cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
ANGI balance_sheet (quarterly, 2026-03-31) — Net Debt: 226809000.00
ANGI income_statement (quarterly, 2026-03-31) — Net Income: -8978000.00
ANGI income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -8978000.00
ANGI income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -8978000.00
ANGI income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -8978000.00
ANGI income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -8978000.00
ANGI cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -8978000.00
ANGI income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -8978000.00
ANGI income_statement (quarterly, 2026-03-31) — Net Interest Income: -2822000.00
ANGI cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -23744000.00
ANGI cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -23744000.00
ANGI income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -2822000.00
ANGI cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1798000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Net PPE: 101373000.00
ANGI cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 32000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -141474000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 125317000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1455000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 125317000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1455000.00
ANGI income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 22513000.00
ANGI income_statement (quarterly, 2026-03-31) — Normalized Income: 2353120.00
ANGI cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -17903000.00
ANGI cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -2739000.00
ANGI income_statement (quarterly, 2026-03-31) — Operating Income: 5459000.00
ANGI income_statement (quarterly, 2026-03-31) — Operating Revenue: 238150000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 40421000.00
ANGI balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 31358000.00
ANGI income_statement (quarterly, 2026-03-31) — Other Gand A: 57931000.00